cyclosporine has been researched along with Becker Muscular Dystrophy in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Belosludtsev, KN; Belosludtseva, NV; Dubinin, MV; Mikheeva, IB; Starinets, VS; Talanov, EY | 1 |
| Belosludtsev, KN; Dubinin, MV; Mikheeva, IB; Starinets, VS | 1 |
| Argenton, F; Bernardi, P; Menazza, S; Merlini, L; Petronilli, V; Sabatelli, P; Schiavone, M; Zulian, A | 1 |
| Becker, TS; Berger, J; Brouilly, N; Currie, PD; Giacomotto, J; Gieseler, K; Mariol, MC; Ségalat, L; Walter, L | 1 |
| Janíček, R; Kyrychenko, V; Poláková, E; Shirokova, N | 1 |
| Babarit, C; Dubreil, L; Goubin, H; Guével, L; Larcher, T; Ledevin, M; Robriquet, F; Rouger, K | 1 |
| Dorchies, OM; Patthey-Vuadens, O; Reutenauer, J; Ruegg, UT; Vuagniaux, G | 1 |
| Bernert, G; Grieben, U; Hobbiebrunken, E; Ihorst, G; Kirschner, J; Korinthenberg, R; Lütschg, J; Müller-Felber, W; Reitter, B; Schara, U; Schessl, J; Schmoor, C; Stehling, F; Stettner, GM; Thiele, S; von der Hagen, M; Weiss, S; Wiegand, G; Wilichowski, E | 1 |
| Griggs, RC | 1 |
| Duan, D; Lai, Y; Shin, JH; Smith, B; Srivastava, A; Yue, Y | 1 |
| Barthélémy, I; Blot, S; Drougard, C; Thibaud, JL; Unterfinger, Y; Uriarte, A | 1 |
| Andreetta, F; Cerletti, M; Colpo, R; Cornelio, F; Cozzi, F; Croci, D; Davies, KE; Gilbert, R; Karpati, G; Mora, M; Negri, T; Pozza, O | 1 |
| Gregorevic, P; Lynch, GS; Plant, DR; Stupka, N | 1 |
| Chen, C; Chen, W; Fang, JP; Feng, HY; Feng, SW; Huang, K; Huang, SL; Li, Y; Li, Z; Liu, Y; Lu, XL; Wen, JM; Xi, J; Xiao, LL; Xie, YM; Xu, HG; Yao, XL; Ye, X; Zeng, Y; Zhang, C; Zhang, M; Zhang, WX; Zhou, DH | 1 |
| Allen, JM; Blankinship, M; Chamberlain, JS; Gregorevic, P; Kuhr, CS; Storb, R; Tapscott, SJ; Wang, Z | 1 |
| Hijikata, T; Howell, JM; Miyagoe-Suzuki, Y; Nakamura, A; Ohshima, S; Takeda, S; Urasawa, N; Yoshimura, M; Yuasa, K | 1 |
1 trial(s) available for cyclosporine and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial.
Topics: Child; Cyclosporine; Double-Blind Method; Humans; Male; Muscular Dystrophy, Duchenne; Review Literature as Topic; Treatment Outcome | 2010 |
15 other study(ies) available for cyclosporine and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Alisporivir Improves Mitochondrial Function in Skeletal Muscle of
Topics: Animals; Cyclophilins; Cyclosporine; Dynamins; Dystrophin; Gene Expression Regulation; GTP Phosphohydrolases; Humans; Mice; Mice, Inbred mdx; Mitochondria; Mitochondria, Muscle; Mitochondrial Dynamics; Mitochondrial Permeability Transition Pore; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2021 |
Effect of Alisporivir on Calcium Ion Transport and Mitophagy in Skeletal Muscle and Heart Mitochondria in Dystrophin-Deficient Mice.
Topics: Animals; Calcium; Cyclosporine; Dystrophin; Ion Transport; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mitochondria, Heart; Mitophagy; Muscle, Skeletal; Muscular Dystrophy, Duchenne | 2022 |
Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy.
Topics: Animals; Cell Respiration; Cells, Cultured; Cyclosporine; Disease Models, Animal; Humans; Membrane Potential, Mitochondrial; Mitochondria; Muscle Cells; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Oxygen Consumption; Zebrafish | 2017 |
Chemical genetics unveils a key role of mitochondrial dynamics, cytochrome c release and IP3R activity in muscular dystrophy.
Topics: Animals; Animals, Genetically Modified; Binding Sites; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cell Death; Cyclophilins; Cyclosporine; Cytochromes c; Gene Knockdown Techniques; Humans; Inositol 1,4,5-Trisphosphate Receptors; Methazolamide; Mitochondrial Dynamics; Mitochondrial Proteins; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Phylogeny; Sequence Homology; Zebrafish | 2013 |
Mitochondrial dysfunctions during progression of dystrophic cardiomyopathy.
Topics: Animals; Calcium; Cells, Cultured; Cyclosporine; Cytosol; Disease Models, Animal; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Muscular Dystrophy, Duchenne; Myocytes, Cardiac; NAD; Oxidative Stress; Sodium | 2015 |
Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.
Topics: Animals; Biomarkers; Cyclosporine; Disease Models, Animal; Dogs; Down-Regulation; Fluorescent Antibody Technique; Humans; Immunosuppression Therapy; Immunosuppressive Agents; In Situ Hybridization; Injections, Intra-Arterial; Mice; Mice, Inbred mdx; MicroRNAs; Muscle Cells; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Myosin Heavy Chains; Stem Cell Transplantation; Stem Cells; Up-Regulation | 2016 |
Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.
Topics: Animals; Animals, Newborn; Cell Death; Cyclophilins; Cyclosporine; Diaphragm; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Hindlimb; Male; Mice; Mice, Inbred mdx; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Necrosis | 2008 |
Duchenne muscular dystrophy: an important negative trial.
Topics: Cyclosporine; Humans; Multicenter Studies as Topic; Muscular Dystrophy, Duchenne; Randomized Controlled Trials as Topic | 2010 |
A simplified immune suppression scheme leads to persistent micro-dystrophin expression in Duchenne muscular dystrophy dogs.
Topics: Animals; Antilymphocyte Serum; Cyclosporine; Dependovirus; Disease Models, Animal; Dogs; Dystrophin; Female; Gene Expression; Genetic Therapy; Genetic Vectors; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Injections, Intramuscular; Male; Mice; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Mycophenolic Acid; T-Lymphocytes; Transgenes | 2012 |
Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy.
Topics: Accelerometry; Animals; Biomechanical Phenomena; Creatine Kinase; Cyclosporine; Disease Models, Animal; Dogs; Follow-Up Studies; Gait; Humans; Immunosuppressive Agents; Motor Activity; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Principal Component Analysis; Tetany | 2012 |
Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
Topics: Adenoviridae; Animals; CD4 Lymphocyte Count; Cyclosporine; Cytoskeletal Proteins; Dog Diseases; Dogs; Dystrophin; Female; Fibrosis; Gene Expression; Genetic Therapy; Genetic Vectors; Immunohistochemistry; Immunosuppressive Agents; Male; Membrane Proteins; Models, Animal; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Transduction, Genetic; Transgenes; Utrophin | 2003 |
The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice.
Topics: Animals; Animals, Newborn; Blotting, Western; Calcineurin; Cyclosporine; Disease Models, Animal; Enzyme Inhibitors; Immunohistochemistry; Isometric Contraction; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Fatigue; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Organ Size; Regeneration; Signal Transduction | 2004 |
[Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
Topics: Alprostadil; Busulfan; Child; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclosporine; Dystrophin; Ganciclovir; Humans; Male; Methylprednisolone; Muscular Dystrophy, Duchenne; Polymerase Chain Reaction; Treatment Outcome | 2005 |
Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression.
Topics: Animals; Antilymphocyte Serum; Cyclosporine; Dependovirus; Dogs; Drug Therapy, Combination; Dystrophin; Flow Cytometry; Gene Expression; Genetic Therapy; Genetic Vectors; Immunosuppression Therapy; Immunosuppressive Agents; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Mycophenolic Acid | 2007 |
Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
Topics: Animals; Base Sequence; beta-Galactosidase; Calmodulin; Cyclosporine; Dependovirus; Dogs; Dystrophin; Genetic Engineering; Genetic Therapy; Genetic Vectors; Immunosuppressive Agents; Injections, Intramuscular; Interferon-gamma; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Models, Animal; Molecular Sequence Data; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Parvoviridae Infections; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Species Specificity; T-Lymphocytes, Cytotoxic; Transduction, Genetic; Transgenes | 2007 |